Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BCAR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC39A13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUTA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFSF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEACAM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35E1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIF1AN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIDT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRRC2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KAZALD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSBPL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VTCN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
F11R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XRCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on